RVLPQ (RVL Pharmaceuticals) Retained Earnings: $-604.72 Mil (As of Jun. 2023)


RVLPQ RVL Pharmaceuticals PLC RVLPQ
12 GF Score
Price $0.00
View Full Analysis

What is RVL Pharmaceuticals Retained Earnings?

RVL Pharmaceuticals RVLPQ -90.00% 12 Retained Earnings is $-604.72 Mil as of Jun. 2023. GuruFocus rates RVLPQ with a GF Score™ of 12/100.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. RVL Pharmaceuticals's retained earnings for the quarter that ended in Jun. 2023 was $-604.72 Mil.

RVL Pharmaceuticals's quarterly retained earnings declined from Dec. 2022 ($-569.22 Mil) to Mar. 2023 ($-580.83 Mil) and declined from Mar. 2023 ($-580.83 Mil) to Jun. 2023 ($-604.72 Mil).

RVL Pharmaceuticals's annual retained earnings declined from Dec. 2020 ($-452.61 Mil) to Dec. 2021 ($-517.53 Mil) and declined from Dec. 2021 ($-517.53 Mil) to Dec. 2022 ($-569.22 Mil).


RVL Pharmaceuticals  (OTCPK:RVLPQ) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


RVL Pharmaceuticals Retained Earnings Historical Data

* Premium members only.

The historical data trend for RVL Pharmaceuticals's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RVL Pharmaceuticals Retained Earnings Chart

RVL Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Retained Earnings
Get a 7-Day Free Trial -102.12 -373.02 -452.61 -517.53 -569.22

RVL Pharmaceuticals Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -536.46 -550.90 -569.22 -580.83 -604.72
RVLPQ
12GF Score
RVL Pharmaceuticals PLC RVLPQ
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RVL Pharmaceuticals Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-604.72 Mil mean?
RVL Pharmaceuticals (RVLPQ) has a Retained Earnings of $-604.72 Mil as of Jun. 2023. Retained earnings is the amount of net income not issued to shareholders. View historical data on RVL Pharmaceuticals and its competitors.
Is RVL Pharmaceuticals' Retained Earnings too high?
RVL Pharmaceuticals' current Retained Earnings is $-604.72 Mil. Overall, RVL Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does RVL Pharmaceuticals' Retained Earnings compare to SNPX and THAR?
RVL Pharmaceuticals' Retained Earnings of $-604.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on RVL Pharmaceuticals and its competitors. RVL Pharmaceuticals's current Retained Earnings is $-604.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RVL Pharmaceuticals stock overvalued right now?
RVL Pharmaceuticals (RVLPQ) has a current Retained Earnings of $-604.72 Mil. The current Retained Earnings is $-604.72 Mil. RVL Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For RVL Pharmaceuticals (RVLPQ), the current Retained Earnings is $-604.72 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RVL Pharmaceuticals Business Description

Address 400 Crossing Boulevard, Bridgewater, NJ, USA, 08807
RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.
12GF Score

Get the complete analysis for RVLPQ

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price